JoyL Silva of Pfizer CentreOne discusses global market and regulatory changes driving drug development strategies and the evolution of CDMO services and ops.
Clinical leaders discuss bringing together disparate processes and systems for improved collaboration and more efficient trial execution at Veeva R&D Summit
Online ExclusivesJim Reilly, vice president of clinical strategy at Veeva Systems10.18.19
A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
Ryan Carpentier, Executive Director of Business Development, Cryoport09.23.19